Travere Therapeutics, Inc. TVTX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s inventories?
- Travere Therapeutics, Inc. (TVTX) reported inventories of $30.7M in Q1 2026.
- How has Travere Therapeutics, Inc.'s inventories changed year-over-year?
- Travere Therapeutics, Inc.'s inventories decreased by 9.9% year-over-year, from $34.07M to $30.7M.
- What is the long-term trend for Travere Therapeutics, Inc.'s inventories?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s inventories has grown at a 31.8% compound annual growth rate (CAGR), from $7.61M to $30.28M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.